Categories: News

Praxis Precision Medicines to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:

  • RBC Capital Markets Global Healthcare Conference
    Presentation on Wednesday, May 19, 2021 at 2:30 p.m. ET
  • Oppenheimer Rare & Orphan Disease Summit
    Prerecorded presentation available on Friday, May 21, 2021 at 8:00 a.m. ET

The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the events.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

CONTACT: Investor Contact:
Alex Kane
Praxis Precision Medicines
investors@praxismedicines.com
617-300-8481

Media Contact:
Ian Stone
Canale Communications
Ian.stone@canalecomm.com
619-849-5388

Staff

Recent Posts

Being a Practice Owner Doesn’t Mean Skipping Holidays—Here’s How You Can Prepare

By Andrew Speight, Chief Marketing Officer at RXNT The holidays are supposed to be a…

10 hours ago

Syra Health to Present at NobleCon20

CARMEL, Ind., Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or…

12 hours ago

AI/ML Innovations Inc. Announces Final Private Placement Closing

VICTORIA, BC / ACCESSWIRE / November 26, 2024 / AI/ML Innovations Inc. ("AI/ML" or the…

12 hours ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced…

12 hours ago

My Compounding of Brisbane Now Offers Compounding Services Across Australia

BRISBANE, AUSTRALIA / ACCESSWIRE / November 26, 2024 / The healthcare landscape in Australia has…

15 hours ago